Patrick Scannon

Director/Board Member at CASSAVA SCIENCES, INC.

Net worth: 14 820 $ as of 29/06/2024

76 year

78 connections

Health Technology

Consumer Services

Commercial Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Remi Barbier	M	64	CASSAVA SCIENCES, INC. XOMA ROYALTY CORPORATION	29 years
Neil E. Reiner	M	-	Indel Therapeutics, Inc. Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^	-
Charles Fisher	M	78	XOMA ROYALTY CORPORATION Flame Biosciences LLC Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.	5 years
Michael O'Donnell	M	65	CASSAVA SCIENCES, INC.	26 years
Jack Wyszomierski	M	68	XOMA ROYALTY CORPORATION	14 years
Michael Marsman	M	-	CASSAVA SCIENCES, INC.	-
Thomas Burns	M	50	XOMA ROYALTY CORPORATION	18 years
Roger Léger	M	-	Indel Therapeutics, Inc. Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^	-
Tim Opler	M	-	Flame Biosciences LLC Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.	-
Robert Stein	M	-	Flame Biosciences LLC Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.	-
Sanford Robertson	M	92	CASSAVA SCIENCES, INC.	26 years
Richard Barry	M	65	CASSAVA SCIENCES, INC.	3 years
Joseph Limber	M	71	XOMA ROYALTY CORPORATION	12 years
Eric Schoen	M	55	CASSAVA SCIENCES, INC.	6 years
Lawrence H. Dubois	M	69	Defense Sciences Research Council	-
Robert Gussin	M	86	CASSAVA SCIENCES, INC.	21 years
Irwin Kuntz	M	-	Indel Therapeutics, Inc. Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^	-
James Kupiec	M	-	CASSAVA SCIENCES, INC.	3 years
Robert Anderson	M	58	CASSAVA SCIENCES, INC.	1 years
Robert Cook	M	60	CASSAVA SCIENCES, INC.	2 years
Seth Putterman	M	78	Defense Sciences Research Council	17 years
Richard J. White	M	82	Indel Therapeutics, Inc. Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^	-
Allan Collings	M	-	Indel Therapeutics, Inc. Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^	13 years
Claude Nicaise	M	71	CASSAVA SCIENCES, INC.	1 years
Michael Zamloot	M	-	CASSAVA SCIENCES, INC.	-
George B. Thornton	M	-	CASSAVA SCIENCES, INC.	-
David Barrett	M	48	Flame Biosciences LLC Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.	5 years
J. P. Benya	M	60	Flame Biosciences LLC Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.	-
Kris Harland Jenner	M	62	Flame Biosciences LLC Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.	-
Joseph P. Miletich	M	-	Flame Biosciences LLC Flame Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Flame Biosciences, Inc. operates as a biotechnology company. The firm offers research, development and commercialization of transformative therapies for cancer and other inflammatory conditions. The company was founded by Charles J. Fisher Jr., Patrick J. Scannon and Bob Stein and is headquartered in New York, NY.	-
Pierre Gravier	M	39	CASSAVA SCIENCES, INC.	1 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
James Neal	M	68	XOMA ROYALTY CORPORATION	14 years
Nadav Friedmann	M	81	XOMA ROYALTY CORPORATION CASSAVA SCIENCES, INC.	28 years
John L. Castello	M	87	XOMA ROYALTY CORPORATION	15 years
W. van Ness	M	81	XOMA ROYALTY CORPORATION	42 years
Steven Engle	M	69	XOMA ROYALTY CORPORATION	4 years
Gary L. Wilcox	M	77	XOMA ROYALTY CORPORATION	4 years
Charles C. Wells	M	73	XOMA ROYALTY CORPORATION	16 years
Christopher J. Margolin	M	77	XOMA ROYALTY CORPORATION	21 years
Judy Ishida	F	-	CASSAVA SCIENCES, INC.	12 years
Daniel P. Cafaro	M	67	XOMA ROYALTY CORPORATION	-
Marvin J. Garrett	M	73	XOMA ROYALTY CORPORATION	5 years
Bill Bowes	M	97	XOMA ROYALTY CORPORATION	31 years
Fred Kurland	M	74	XOMA ROYALTY CORPORATION	7 years
Sona Saira Ramasastry	F	48	CASSAVA SCIENCES, INC.	7 years
Timothy Walbert	M	57	XOMA ROYALTY CORPORATION	7 years
John Varian	M	64	XOMA ROYALTY CORPORATION	9 years
Peter Hutt	M	89	XOMA ROYALTY CORPORATION	12 years
Patricia Donahue	F	-	XOMA ROYALTY CORPORATION	-
Mary L. Anderson	F	-	XOMA ROYALTY CORPORATION	-
Paul D. Goodson	M	-	XOMA ROYALTY CORPORATION	-
Kelvin Neu	M	50	XOMA ROYALTY CORPORATION	3 years
James G. Andress	M	85	XOMA ROYALTY CORPORATION	13 years
Phillip Young	M	-	XOMA ROYALTY CORPORATION	15 years
Bo Purtic	M	-	XOMA ROYALTY CORPORATION	2 years
Thomas Klein	M	62	XOMA ROYALTY CORPORATION	-
Marc D. Better	M	68	XOMA ROYALTY CORPORATION	5 years
Patrick Rivers	M	-	XOMA ROYALTY CORPORATION	4 years
Howard Levine	M	-	XOMA ROYALTY CORPORATION	5 years
Erik Emerson	M	53	XOMA ROYALTY CORPORATION	3 years
Calvin L. McGoogan	M	-	XOMA ROYALTY CORPORATION	-
Peter S. Roddy	M	64	CASSAVA SCIENCES, INC.	15 years
Marilyn A. Lobel	F	70	XOMA ROYALTY CORPORATION	1 years
Stephen Doberstein	M	65	XOMA ROYALTY CORPORATION	-
Todd J. Lorenz	M	70	XOMA ROYALTY CORPORATION	4 years
Robert S. Tenerowicz	M	-	XOMA ROYALTY CORPORATION	-
Vernon R. Loucks	M	89	CASSAVA SCIENCES, INC.	4 years
Grant L. Schoenhard	M	79	CASSAVA SCIENCES, INC.	14 years
Steven C. Mendell	M	83	XOMA ROYALTY CORPORATION	-
Clarence L. Dellio	M	78	XOMA ROYALTY CORPORATION	20 years
Paul D. Rubin	M	70	XOMA ROYALTY CORPORATION	5 years
Ronald H. Carlson	M	70	XOMA ROYALTY CORPORATION	7 years
J. Boyle	M	70	XOMA ROYALTY CORPORATION	3 years
Daniel J. Gennevois	M	69	XOMA ROYALTY CORPORATION	3 years
Peter Y. Tam	M	60	XOMA ROYALTY CORPORATION	4 years
Patrick Zenner	M	77	XOMA ROYALTY CORPORATION	8 years
Peter B. Davis	M	77	XOMA ROYALTY CORPORATION	11 years
Brion Raymond	M	54	XOMA ROYALTY CORPORATION	1 years

Statistics

Country	Connections	% of total
United States	73	93.59%
Canada	5	6.41%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections